Ignite Creation Date:
2024-05-06 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 2:27 PM
Study NCT ID:
NCT05285566
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2022-03-09
Brief Title:
Pain Control for Undergoing Costal Cartilage Harvesting
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
A Phase IV Randomized Single-Blind Trial of Liposomal Bupivacaine Exparel for Pain Control in Costal Cartilage Harvest
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out whether injecting the US Food and Drug Administration FDA approved drug EXPAREL a long acting approximately 96 hours numbing medication will reduce pain after rib cartilage removal in comparison to the standard injection of XYLOCAINE
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None